Masked Hypertension: Clinical Trials

2 trials for Masked Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Withdrawn 1

Follow Masked Hypertension: new trials by email Literature Review of Masked Hypertension trials Research Report on Masked Hypertension

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanism of Masked Hypertension - Intervention
Carvedilol, Amlodipine - Masked Hypertension
Phase 3WithdrawnUniversity of Alabama at Birmingham2021-07-012021-11-05
Treatment of Masked Hypertension
Antihypertensive medication intensification, Usual care - Masked Hypertension, Hypertension
Phase 3CompletedUniversity of Minnesota42014-06-012017-12-29

Narrower conditions

Hypertension (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hypertension (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Amlodipine (1)  ·  Carvedilol (1)

Sponsors

University of Alabama at Birmingham (1)  ·  University of Minnesota (1)

Countries

United States (2)

Top investigators

Paul E Drawz, MD, MHS, MS (1)